Vicente Alberola

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

Reginald V. Lord, Jan Brabender, David R. Gandara et al. · PubMed · 2002 · 671 citations

Medicine, Molecular Biology, Oncology +14

Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

Felipe Cardenal, M.P. López-Cabrerizo, Antonio Antón et al. · Journal of Clinical Oncology · 1999 · 476 citations

Medicine, Oncology, Pharmacology +10

Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung Cancer

Manuel Cobo, Dolores Isla, Bartomeu Massutí et al. · Journal of Clinical Oncology · 2007 · 442 citations · Full text

Medicine, Molecular Medicine, Oncology +10

Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non–Small-Cell Lung Cancer

Enriqueta Felip, Rafael Rosell, J Maestre et al. · Journal of Clinical Oncology · 2010 · 430 citations · Full text

Medicine, Oncology, Surgery +17

Paclitaxel Resistance in Non–Small-Cell Lung Cancer Associated With Beta-Tubulin Gene Mutations

Mariano Monzó, Rafael Rosell, José Javier Sánchez et al. · Journal of Clinical Oncology · 1999 · 315 citations

Medicine, Oncology, Pharmacology +17